1 栗德林，余传隆，杨思澎，等主编.中国药物大辞典.北京:中国医药科技出版社，1991:2556.
2 方积年:多糖研究的现状，药学学报，1986；21(12):944.
3 Takashi M: A development of antitumor polysaccharides from mushroom fungi. Food Ingredients J,1996,167:69.
4 Goro C, Juji H, Yukiko YM, et al .Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from lentinus edodes. Cancer Res, 1970,30:2776.
5 福岡文子.致癌性物質制造法日本特許公報，昭49-484.1974.
6 Mashihi KN, Lange W. Immunotherapeutic Prospects of Infections diseases. Berlin: Springer-Verlag, 1990:9.
7 Saito H, Ohki T, Sasaki T. A 13<\sup> C NMR study of polysaccharide gels, moleculer architecture in the gels activity of fungal, branched(1 3)- -D-glucan as manifected by conformational change induced by Na<\sub>OH, Carbohydr Res,1979,74:227
8 Nanba H, Kuroda H. The chemical structure of an，antitumor polysaccharide in mycelia of Cochliobolus
myabeanus. Chem Pharm Bull, 1987,35:1285.
9 Takusaburo E, Kaguko M. Antitumor effect of intramoral administration of BRM: inhibition of tumor cell invasion in vitro .Gan To Kagaku Ryoho,1995,22(11),1626.
10 Zakany J, Chihara G, Fachet J. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. Int J Cancer, 1980, 25: 371.
11 Suga T, Shiio T, Maeda YY. Antitumor actitivity of lentinan in murine syngeneic and antochthonous hosts and its suppressive effect on 3-methyl-chlolanthrene-induced carcin-ogeneisis. Cancer Res, 1984,44:5132.
12 Lapis K, Papay ], Paku S, et al .The effect of lentinan on the metastais of Lewis lung carcinoma. Int J Immunoth-erapy,1989;11(5):195
13 Urushiya KI. Host laefertse Mechanisms Against Cancer.Amsterdan: Excerta Medica, 1986:167.
14 Zakang J, Chihara G, Fachet J. Effect of lentinan on tumor growth in murine allogeneic and syngeneic, Int .J Cancer,1980,25:371.
15 Namiki F, Kikuchi R, Tomoko K. et al.Lentinan augments skin reaction induced by bradgkinin: It's corre-lation with rescular dilatation and hemorrhage responses and antitumor activites, Ittt J Immunopharmacol.1995;17(6):465.
16 Fachet J, Abel G, Jusupova A, et al .Potentiation non-specific host defense by polysaccharides like lentinan: posible mechanisms. Int J Immunotherapy, 1989,11(5):167.
17 Tsubura E. Rationale of Biological Response Modifiers in Cancer Treatment .Amsterdam: Excerpts Medics, 1985:151.
18 Setji T, Susumu S, Kenichi T. Antitumor activities enhancers containing histamine for immunostimulating antitumor agents and antitumor compositions. Jpn Kokai Tokkyo Koho JP 07,165,582,27 Jun. 1995.
19 Suzuki M. Induction of endogeneous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2. Int J Immunopharmacol, 1990,12(6)，613.
20 Jone S G, Birmingham J M. Lentinan, a biological response modifier. Adv Appl Microbiology, 1993,39:157.
21 Kanai K, Kondo E, Jacques P J. Immunopotentiating effect of fungal glucans as revealed by frequency limitation of posy-chemotherapy relapse in mouse experimental tuberculosis.Jpn J Med Sci Biol, 1980,30:283.
22 Fukushi K, Ogasawa K. Lentinan for prophylactic and therapeutic treatment of complications after lensectomy, Jpn Kokai Tokkyo Koho, JP02,164,282,18. Jun. 1990.
23 Kaneko Y, Chihara G, Taguchi T. Activity of lentinan against cancer and AIDS. Int J Immunotherapy, 1989,11(5):203.
24 方积年.硫酸醋化多糖的研究进展.中国药学杂志，1993,28(7):393.
